• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从小鼠肉瘤180条件培养基中纯化和鉴定两种胶原酶抑制剂。

Purification and characterization of two collagenase inhibitors from mouse sarcoma 180 conditioned medium.

作者信息

Rosenthal R A, Moses M A, Shintani Y, Megyesi J F, Langer R, Folkman J

机构信息

Department of Surgery, Children's Hospital, Boston, Massachusetts 02115.

出版信息

J Cell Biochem. 1994 Sep;56(1):97-105. doi: 10.1002/jcb.240560114.

DOI:10.1002/jcb.240560114
PMID:7806596
Abstract

We have previously shown that mouse sarcoma 180 cells produce vascular endothelial growth factor [VEGF; Rosenthal et al., 1990, Growth Factors, 4: 53-59], an endothelial mitogen that stimulates angiogenesis. Recent reports have implicated metalloproteinases and their inhibitors in the regulation of vascular morphogenesis, tumor invasion, and metastasis. We report here that mouse sarcoma 180 cells produce two collagenase inhibitors. These inhibitors were purified by heparin-Sepharose affinity chromatography, gel filtration, and C4 reverse phase h.p.l.c. Analytical gel electrophoresis of the purified inhibitors (MS-22 and MS-31) revealed molecular masses of 22,000 and 31,000 Da under reducing conditions, and 20,000 and 30,000 Da under nonreducing conditions, respectively. The NH2-terminal amino acid sequence of MS-22 was identical to that of tissue inhibitor of metalloproteinases type 2 (TIMP-2) produced by human melanoma cells [Stetler-Stevenson et al., 1989, J. Biol. Chem. 264: 17374-17378) over the first 30 amino acids. The NH2-terminal amino acid sequence of MS-31 was identical to that of murine TIMP-1 [Gewert et al., 1989, EMBO J 6:651-657]. Statistical analysis of the amino acid composition data of these two mouse sarcoma 180-derived collagenase inhibitors confirms the identification of MS-22 as TIMP-2 and MS-31 as TIMP-1.

摘要

我们先前已表明,小鼠肉瘤180细胞可产生血管内皮生长因子[VEGF;Rosenthal等人,1990年,《生长因子》,4:53 - 59],一种刺激血管生成的内皮细胞有丝分裂原。最近的报告表明金属蛋白酶及其抑制剂参与血管形态发生、肿瘤侵袭和转移的调控。我们在此报告,小鼠肉瘤180细胞可产生两种胶原酶抑制剂。这些抑制剂通过肝素 - 琼脂糖亲和层析、凝胶过滤和C4反相高效液相色谱法进行纯化。纯化后的抑制剂(MS - 22和MS - 31)在还原条件下的分析凝胶电泳显示分子量分别为22,000和31,000 Da,在非还原条件下分别为20,000和30,000 Da。MS - 22的NH2末端氨基酸序列在前30个氨基酸上与人黑色素瘤细胞产生的金属蛋白酶组织抑制剂2(TIMP - 2)[Stetler - Stevenson等人,1989年,《生物化学杂志》264:17374 - 17378]相同。MS - 31的NH2末端氨基酸序列与鼠源TIMP - 1 [Gewert等人,1989年,《欧洲分子生物学组织杂志》6:651 - 657]相同。对这两种源自小鼠肉瘤180的胶原酶抑制剂的氨基酸组成数据进行统计分析,证实MS - 22为TIMP - 2,MS - 31为TIMP - 1。

相似文献

1
Purification and characterization of two collagenase inhibitors from mouse sarcoma 180 conditioned medium.从小鼠肉瘤180条件培养基中纯化和鉴定两种胶原酶抑制剂。
J Cell Biochem. 1994 Sep;56(1):97-105. doi: 10.1002/jcb.240560114.
2
A fibroblast elongation factor purified from colon carcinoma cells shares sequence identity with TIMP-1.
Biochem Biophys Res Commun. 1995 Jan 17;206(2):590-600. doi: 10.1006/bbrc.1995.1084.
3
Secreted inhibitors of metalloproteinases (IMPs) that are distinct from TIMP.
Matrix Suppl. 1992;1:294-8.
4
TIMP-2: identification and characterization of a new member of the metalloproteinase inhibitor family.
Matrix Suppl. 1992;1:299-306.
5
Directed mutagenesis reveals that two histidines in tissue inhibitor of metalloproteinase-1 are each essential for the suppression of cell migration, invasion, and tumorigenicity.定向诱变显示,金属蛋白酶组织抑制剂-1中的两个组氨酸对于抑制细胞迁移、侵袭和致瘤性均必不可少。
Cell Growth Differ. 1996 Nov;7(11):1579-88.
6
Studies on the effects of laminin, E-8 fragment of laminin and synthetic laminin peptides PA22-2 and YIGSR on matrix metalloproteinases and tissue inhibitor of metalloproteinase expression.层粘连蛋白、层粘连蛋白E-8片段以及合成层粘连蛋白肽PA22-2和YIGSR对基质金属蛋白酶和金属蛋白酶组织抑制剂表达影响的研究
Lab Invest. 1994 Jun;70(6):800-6.
7
A paracrine migration-stimulating factor for metastatic tumor cells secreted by mouse hepatic sinusoidal endothelial cells: identification as complement component C3b.
Cancer Res. 1993 Sep 15;53(18):4418-23.
8
Purification and sequence analysis of two rat tissue inhibitors of metalloproteinases.两种大鼠金属蛋白酶组织抑制剂的纯化与序列分析
Arch Biochem Biophys. 1992 Feb 1;292(2):402-10. doi: 10.1016/0003-9861(92)90009-l.
9
Type IV collagenase(s) and TIMPs modulate endothelial cell morphogenesis in vitro.IV型胶原酶和金属蛋白酶组织抑制剂在体外调节内皮细胞形态发生。
J Cell Physiol. 1993 Aug;156(2):235-46. doi: 10.1002/jcp.1041560204.
10
Leukemic cells (HL-60) produce a novel extracellular matrix-degrading proteinase that is not inhibited by tissue inhibitors of matrix metalloproteinases (TIMPs).白血病细胞(HL-60)产生一种新型的细胞外基质降解蛋白酶,该酶不受基质金属蛋白酶组织抑制剂(TIMPs)的抑制。
Exp Hematol. 1995 Feb;23(2):155-60.

引用本文的文献

1
TIMP-2 (tissue inhibitor of metalloproteinase-2) regulates MMP-2 (matrix metalloproteinase-2) activity in the extracellular environment after pro-MMP-2 activation by MT1 (membrane type 1)-MMP.金属蛋白酶组织抑制因子2(TIMP-2)在MT1-MMP(膜型1基质金属蛋白酶)激活前体MMP-2后,调节细胞外环境中MMP-2(基质金属蛋白酶-2)的活性。
Biochem J. 2003 Sep 15;374(Pt 3):739-45. doi: 10.1042/BJ20030557.
2
Gelatinase-A (MMP-2), gelatinase-B (MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of the pathophysiology of malignant gliomas.明胶酶-A(基质金属蛋白酶-2)、明胶酶-B(基质金属蛋白酶-9)和膜型基质金属蛋白酶-1(MT1-MMP)参与了恶性胶质瘤病理生理学的不同方面。
Br J Cancer. 1999 Apr;79(11-12):1828-35. doi: 10.1038/sj.bjc.6690291.
3
Antiangiogenesis as a novel therapeutic concept in pediatric oncology.抗血管生成作为儿科肿瘤学中的一种新型治疗理念。
J Mol Med (Berl). 1995 Oct;73(10):497-508. doi: 10.1007/BF00198901.